Stopping guidelines for an effectiveness trial: what should the protocol specify?

BACKGROUND: Despite long-standing problems in decisions to stop clinical trials, stopping guidelines are often vague or unspecified in the trial protocol. Clear, well-conceived guidelines are especially important to assist the data monitoring committees for effectiveness trials. MAIN TEXT: To specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyson, Jon E., Pedroza, Claudia, Wallace, Dennis, D’Angio, Carl, Bell, Edward F., Das, Abhik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862046/
https://www.ncbi.nlm.nih.gov/pubmed/27165260
http://dx.doi.org/10.1186/s13063-016-1367-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862046/
https://www.ncbi.nlm.nih.gov/pubmed/27165260
http://dx.doi.org/10.1186/s13063-016-1367-4

Ejemplares similares